Huron Digital Pathology Receives CE-IVD Mark for TissueScope iQ Scanner

Huron Digital Pathology has received a CE-IVD mark for its high throughput TissueScope iQ 400 slide whole slide scanner.

The CE mark indicates that the TissueScope iQ scanner complies with the European In Vitro Diagnostic Regulations. With this certification, Huron accelerates its entry into the diagnostic pathology market in Europe and other key geographies globally to help laboratories keep pace with the rising cancer burden.

All three TissueScope scanner models are now CE-IVD and Health Canada certified.

Learn more about TissueScope iQ here.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Huron Digital Pathology. (2023, April 14). Huron Digital Pathology Receives CE-IVD Mark for TissueScope iQ Scanner. News-Medical. Retrieved on October 03, 2023 from https://www.news-medical.net/news/20210310/Huron-Digital-Pathology-Receives-CE-IVD-Mark-for-TissueScope-iQ-Scanner.aspx.

  • MLA

    Huron Digital Pathology. "Huron Digital Pathology Receives CE-IVD Mark for TissueScope iQ Scanner". News-Medical. 03 October 2023. <https://www.news-medical.net/news/20210310/Huron-Digital-Pathology-Receives-CE-IVD-Mark-for-TissueScope-iQ-Scanner.aspx>.

  • Chicago

    Huron Digital Pathology. "Huron Digital Pathology Receives CE-IVD Mark for TissueScope iQ Scanner". News-Medical. https://www.news-medical.net/news/20210310/Huron-Digital-Pathology-Receives-CE-IVD-Mark-for-TissueScope-iQ-Scanner.aspx. (accessed October 03, 2023).

  • Harvard

    Huron Digital Pathology. 2023. Huron Digital Pathology Receives CE-IVD Mark for TissueScope iQ Scanner. News-Medical, viewed 03 October 2023, https://www.news-medical.net/news/20210310/Huron-Digital-Pathology-Receives-CE-IVD-Mark-for-TissueScope-iQ-Scanner.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post
You might also like...
Patient Outcomes of Prostate Cancer with Whole Slide Imaging